Etidronate Disodium
Overview
Etidronate disodium is a bisphosphonate used in the treatment of conditions characterized by abnormal bone resorption, such as osteoporosis and Paget's disease. It works by inhibiting osteoclast-mediated bone resorption, thus modulating bone metabolism.
API suppliers (3)
Suppliers of Etidronate Disodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 1 of 3 suppliers.
1 of 3 holds a GMP certificate on record in the EU or UK registers
- MEDICHEM SASpain GMP on record
- BOMBAY DRUGS AND PHARMAS LTD
- VIS FARMACEUTICI INSTITUTO SCIENTIFICO VINEZIE SPA
Therapeutic areas
Do you supply Etidronate Disodium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.